1. Age 18 to 60 years <br/ >2. Virological diagnosis of SARS-CoV2 infection <br/ > (PCR) <br/ >3. Patients who are in moderate ARDS following <br/ > COVID-19 infection, as defined by PaO2/FiO2 <br/ > ratio of <200, or more than 25% <br/ > deterioration from the immediate previous <br/ > value within 24hrs in patient having <br/ > po2/fio2 >200. <br/ >4. Baseline serum ferritin level â?¥400ng/mL or <br/ > IL-6 levels greater than 4 times the upper <br/ > limit of normal (ULN) would be included. <br/ >

1. Age 18 to 60 years <br/ >2. Virological diagnosis of SARS-CoV2 infection <br/ > (PCR) <br/ >3. Patients who are in moderate ARDS following <br/ > COVID-19 infection, as defined by PaO2/FiO2 <br/ > ratio of <200, or more than 25% <br/ > deterioration from the immediate previous <br/ > value within 24hrs in patient having <br/ > po2/fio2 >200. <br/ >4. Baseline serum ferritin level â?¥400ng/mL or <br/ > IL-6 levels greater than 4 times the upper <br/ > limit of normal (ULN) would be included. <br/ >

1. Age 18 to 60 years <br/ >2. Virological diagnosis of SARS-CoV2 infection <br/ > (PCR) <br/ >3. Patients who are in moderate ARDS following <br/ > COVID-19 infection, as defined by PaO2/FiO2 <br/ > ratio of <200, or more than 25% <br/ > deterioration from the immediate previous <br/ > value within 24hrs in patient having <br/ > po2/fio2 >200. <br/ >4. Baseline serum ferritin level â?¥400ng/mL or <br/ > IL-6 levels greater than 4 times the upper <br/ > limit of normal (ULN) would be included. <br/ >

1. Age 18 to 60 years <br/ >2. Virological diagnosis of SARS-CoV2 infection <br/ > (PCR) <br/ >3. Patients who are in moderate ARDS following <br/ > COVID-19 infection, as defined by PaO2/FiO2 <br/ > ratio of <200, or more than 25% <br/ > deterioration from the immediate previous <br/ > value within 24hrs in patient having <br/ > po2/fio2 >200. <br/ >4. Baseline serum ferritin level â?¥400ng/mL or <br/ > IL-6 levels greater than 4 times the upper <br/ > limit of normal (ULN) would be included. <br/ >